Invention Grant
- Patent Title: Edaravone dosage form
-
Application No.: US16084668Application Date: 2017-04-21
-
Publication No.: US11020375B2Publication Date: 2021-06-01
- Inventor: Xinfu Zhou , Ankit Parikh , Sanjay Garg
- Applicant: SUZHOU AUZONE BIOLOGICAL TECHNOLOGY CO., LTD
- Applicant Address: CN Suzhou
- Assignee: SUZHOU AUZONE BIOLOGICAL TECHNOLOGY CO., LTD
- Current Assignee: SUZHOU AUZONE BIOLOGICAL TECHNOLOGY CO., LTD
- Current Assignee Address: CN Suzhou
- Agency: Dilworth IP, LLC
- Priority: CN201610149832.9 20160316
- International Application: PCT/CN2017/081405 WO 20170421
- International Announcement: WO2017/157350 WO 20170921
- Main IPC: A61K31/4152
- IPC: A61K31/4152 ; A61K47/14 ; A61K9/10 ; A61K9/107 ; A61K47/44 ; A61K47/34 ; A61K9/08 ; A61K47/02 ; A61K47/22
Abstract:
Disclosed is an Edaravone dosage form and a use thereof in preparing a drug used for treating diseases related to oxidative stress, the dosage form being selected from a lipid-based delivery system, a solid dispersion, micelles and a co-solvent based formulation.
Public/Granted literature
- US20190083463A1 EDARAVONE DOSAGE FORM Public/Granted day:2019-03-21
Information query
IPC分类:
